Nimodipine: Aneurysmal Subarachnoid Hemorrhage, Enteral Dosing and Safety
Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling. Overview and correct indication Nimodipine is a lipophilic dihydropyridine L-type calcium channel blocker with an established role in improving neurologic outcomes following aneurysmal subarachnoid hemorrhage (aSAH). Although its vascular effects may reduce calcium-dependent vasoconstriction,…